A Seattle startup called A-Alpha Bio has closed a $2.8 million seed round for a drug discovery platform that can sort through millions of protein interactions at once.

A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s machine ...

A-Alpha Bio is working with Lawrence Livermore National Laboratory on a project that focuses on rapid countermeasures against future biothreats. Sea-Tac expects near-record number of travelers ...

In the case of A-Alpha Bio, the answer is simple: a $22.4 million funding round and a bright future. A-Alpha Bio, born from the University of Washington's Institute for Protein Design, ...

A-Alpha Bio’s technology analyzes millions of protein-protein interactions simultaneously, a capability that speeds up drug discovery research. Biotech industry partners are already using the ...